Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism

NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis

(2014) J. A. Berzofsky et al.   JOURNAL OF IMMUNOLOGY

Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1

(2010) Shoba Amarnath et al.   PLOS BIOLOGY

IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation

(2009) C. Bucher et al.   BLOOD

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

(2009) H. E. Kohrt et al.   BLOOD

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation

(2009) Jiang Cao et al.   LEUKEMIA RESEARCH

Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation

(2009) Jie Yang et al.   TRANSFUSION

Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL-10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells

(2008) Jason E. Foley et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION